Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Resistance to Imatinib mesylate (IM) is an emerging problem for patients with chronic myelogenous leukemia (CML). T315I mutation in the Bcr-Abl is the predominant mechanism of the acquired resistance to IM and second generation tyrosine kinase inhibitors (TKI). Therefore it is urgent to search for n...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xin, Shi, Xianping, Zhao, Chong, Li, Xiaofen, Lan, Xiaoying, Liu, Shouting, Huang, Hongbiao, Liu, Ningning, Liao, Siyan, Zang, Dan, Song, Wenbin, Liu, Quentin, Carter, Bing Z., Dou, Q. Ping, Wang, Xuejun, Liu, Jinbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253423/
https://www.ncbi.nlm.nih.gov/pubmed/25193854

Ejemplares similares

Ejemplares similares